Background Scarce data are available on what variables affect the risk of transmission of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of …

Background Convalescent plasma has been proposed as an early treatment to interrupt the
progression of early COVID-19 to severe disease, but there is little definitive evidence. We …

… Bárbara Baró is a Beatriu de Pinós postdoctoral fellow granted by the Government of
Catalonia's Secretariat for Universities and Research, and by Marie Sklodowska-Curie Actions …

Background Mass testing for early identification and isolation of infectious COVID-19 individuals
is efficacious for reducing disease spread. Antigen-detecting rapid diagnostic tests (Ag-…

Data on convalescent plasma (CP) treatment in COVID-19 outpatients are scarce. We aimed
to assess whether CP administered during the first week of symptoms reduced the disease …

The SARS-CoV-2 global pandemic created an unprecedented need for rapid, sensitive, and
inexpensive point-of-care (POC) diagnostic tests to treat and control the disease. Many POC …

Background Many countries have resumed mass-gathering events like music festivals, despite
the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading. In …

Background The presence of Plasmodium vivax malaria parasites in the human bone
marrow (BM) is still controversial. However, recent data from a clinical case and experimental …

Background: During the COVID-19 pandemic, lockdown strategies have been widely used
to contain SARS-CoV-2 virus spread. Children and adolescents are especially vulnerable to …

Background Despite their clear lesser vulnerability to COVID-19, the extent by which
children are susceptible to getting infected by SARS-CoV-2 and their capacity to transmit the …